title: [Stenotrophomonas maltophilia and tigecycline in clinical practice].
authors.forename: David
authors.initials: D
authors.lastname: Conde-Estévez
authors.forename: Santiago
authors.initials: S
authors.lastname: Grau
authors.forename: Francisco
authors.initials: F
authors.lastname: Alvarez-Lerma
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002353:Carrier State / Q000188:drug therapy / Q000382:microbiology; D002986:Clinical Trials as Topic; D003428:Cross Infection / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D056687:Off-Label Use; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D017410:Practice Guidelines as Topic; D016879:Salvage Therapy; D018461:Soft Tissue Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D020615:Stenotrophomonas maltophilia / Q000187:drug effects / Q000302:isolation & purification* / Q000276:immunology; D000078304:Tigecycline
chemical_list: D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline